Camellia sells participation in Siegfried
UK-listed Camellia plc agreed to sell 32.27% in SIX-listed Siegfried Holding AG, a Swiss pharmaceutical company, to a number of investors for a total consideration of approximately CHF 80 million. The transaction is conditional on, among others, Siegfried's proposed capital raising being approved by its shareholders at the forthcoming AGM, which is scheduled to take place in April 2010.
Lenz & Staehelin advises Camellia in this transaction. The team includes Rudolf Tschäni, Tino Gaberthüel and Lorenzo Togni.